| 9:00 - 9:15 AM |
|
Opening Remarks |
|
| Session 1: Trends in Reaction Engineering using Artificial Intelligence and Machine Learning |
| 9:15 - 11:30 AM |
Chair |
Ryan Hartman |
|
| |
9:15-10:00AM |
Reaction engineering, ML, and automation for chemical discovery and development |
Klavs Jensen (MIT) |
| |
10:00-10:30 AM |
Autonomous, Algorithmic Process Optimization in the Mettler Toledo AutoChem Ecosystem |
Keith Mattern (Merck) |
| |
10:30-11:00 AM |
Coupling reaction engineering with data-rich experimentation to guide the impurity control strategy for CELMoD API reactions |
Geoff Purdum (BMS) |
| |
11:00-11:30 AM |
Panel Discussion |
|
| 11:30 AM- 12:30PM |
Lunch |
|
|
| Session 2: Reaction Engineering in Process Intensification |
| 12:30 - 3:15 PM |
Chair |
Jon McMullen |
|
| |
12:30-1:15PM |
Flexible Automation Enables Autonomous Process Optimization |
Jason Hein (U. British Columbia) |
| |
1:15-1:45PM |
Leveraging Small Data for Faster Optimization and Enhanced Results in Pharmaceutical Development |
Daniela Blanco (Sunthetics) |
| |
1:45-2:15 PM |
Doing more with less: Value of Process Intensification Techniques for Small Molecule Synthesis |
Jayachandran Devaraj (Corteva) |
| |
2:15-2:45PM |
Tracking lot genealogy in continuous drug substance manufacturing processes through mechanistic modeling |
Dana Barrasso (Siemens) |
| 3:15- 3:30PM |
Break |
|
|
| Session 3: Next Practices in Transport and Novel catalyses |
| 3:30 - 6:15 PM |
Chair |
Marty Johnson |
|
| |
3:30-4:15PM |
Novel Batch and Continuous Syntheses of the HIV Integrase Inhibitor, Dolutegravir |
Thomas Roper (Virginia Commonwealth University) |
| |
4:15-4:45 PM |
Challenges and opportunities in emerging reaction technologies in pharmaceutical development with a focus on photochemistry scale-up |
Melda Sezen Edmonds (BMS) |
| |
4:45-5:15 PM |
Photochemical process design, scale-up, and manufacturing |
Kevin Nagy (Snapdragon) |
| |
5:15-5:45 PM |
Process Development and Scale-up of a Photochemical Reaction for Drug Substance Manufacturing |
Jon McMullen (Merck) |
| |
5:45-6:15 PM |
Evolution of a platform for aerobic processes |
Joe Martinelli (Eli Lilly) |
| 6:15 - 7:30 PM |
Reception |
|
|
| 8:00 - 9:00 AM |
Breakfast |
|
|
| Session 4: New Frontiers in Atypical Reactors and Reactor Design |
| 9:00 - 11:45 AM |
Chair |
Andy Bommarius |
|
|
| |
9:00-9:45AM |
Continuous Reactors for API Manufacturing |
Martin D. Johnson ( Eli Lilly) |
| |
9:45-10:15 AM |
A CDMO Perspective on Continuous Processing Scale-Up: Solving Process Development Challenges using Flexible Equipment Designs and Reaction Modelling |
Ryan Woods (AMPAC Fine Chemicals) |
| |
10:15-10:30 AM |
Break |
|
| |
10:30-11:00AM |
Criteria for selection of continuous reactor and approach to scale-up in API pilot plant for multi kilo production |
Onkar Manjrekar (Abbvie) |
| |
11:00-11:30 AM |
First-Principle Models for Process Monitoring and Risk Assessment in Continuous Pharmaceutical Syntheses |
Neda Nazemifard (Takeda) |
| |
11:30AM-12:00PM |
Food for Thought - Unusual Sources of Inspiration for Reactor Designs |
Luke Rogers (On Demand Pharma) |
| 12:00PM- 1:00PM |
Lunch |
|
|
| Session 5: Future of Pharmaceutical Reaction Engineering |
| 1:00 - 3:30 PM |
Chair |
Moiz Diwan |
|
| |
1:00-1:45PM |
Data-Centric Intensification of the Laboratory for the Development of Mechanisms |
Ryan Hartman (NYU) |
| |
1:45-2:15 PM |
Scaleup Considerations for Solid-Phase Peptide Synthesis in Highly Dynamic Packed Beds |
Harrison Rose (Merck) |
| |
2:15-2:45PM |
Utilizing Online LCMS to Improve the Development of Solid-Phase Peptide Synthesis (SPPS) |
Mark Berglund (Eli Lilly) |
| |
2:45-3:15PM |
Development and Application of High-Throughput Experimentation to Guide Scalable Flow Syntheses of NCE and API |
David Thompson (Purdue) |
| |
3:15-3:45PM |
Mechanistic Modeling of in-Vitro Transcription for mRNA Production |
Nathan Stover (MIT) |
| 3:45-4:00PM |
Closing remarks |
|
|
